Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLC599 in Osteoarthritis of the Knee
NCT02803307Phase 2Completed
- Sponsor
- Taiwan Liposome Company
- Start
- Jun 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TLC599 in osteoarthritis (OA), sponsored by Taiwan Liposome Company. Started Jun 2015; status: completed.
02
Drugs
TLC599
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02803307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02803307.